Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature
- PMID: 20737180
- DOI: 10.1007/s10072-010-0386-2
Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature
Abstract
Idiopathic Parkinson's disease (PD) and progressive supranuclear palsy (PSP) are distinct clinicopathological entities characterized by α-synuclein and tau pathology, respectively. They have occasionally been reported to co-exist in the same patient. We describe a rare case of a 73-year-old Caucasian woman diagnosed as idiopathic PD 5 years before her death yet at autopsy had not only PD, but also PSP. Although this patient fulfilled clinical criteria for idiopathic PD and did not have supranuclear ophthalmoplegia, she had several atypical features, including early postural instability with falls, early dysphagia, and a relatively rapid course. In conclusion, this case and a literature review highlight the co-existence of synuclein and tau pathology in the same patient and demonstrate that multiple diagnoses may exist in patients presenting with parkinsonism. The clinical heterogeneity seen in parkinsonism may reflect the occurrence of combined pathology.
Similar articles
-
Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.Neuropathology. 2016 Apr;36(2):187-91. doi: 10.1111/neup.12259. Epub 2015 Sep 21. Neuropathology. 2016. PMID: 26388542
-
Co-occurrence of Parkinson's disease with progressive supranuclear palsy.Acta Neuropathol. 2002 May;103(5):526-30. doi: 10.1007/s00401-001-0483-7. Epub 2002 Jan 17. Acta Neuropathol. 2002. PMID: 11935271
-
"Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.Neurol Sci. 2021 Dec;42(12):4927-4936. doi: 10.1007/s10072-021-05601-8. Epub 2021 Sep 17. Neurol Sci. 2021. PMID: 34532773 Review.
-
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):615-20. doi: 10.1136/jnnp.60.6.615. J Neurol Neurosurg Psychiatry. 1996. PMID: 8648326 Free PMC article.
-
[Progressive supranuclear palsy].Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(5):111-119. doi: 10.17116/jnevro2021121051111. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34184486 Review. Russian.
Cited by
-
Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.Front Neuroanat. 2015 Mar 11;9:25. doi: 10.3389/fnana.2015.00025. eCollection 2015. Front Neuroanat. 2015. PMID: 25814937 Free PMC article.
-
Comorbid pathologies and their impact on progressive supranuclear palsy: current view.J Neural Transm (Vienna). 2025 Aug 12. doi: 10.1007/s00702-025-03005-y. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 40794238 Review.
-
Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.Mov Disord Clin Pract. 2014 Oct 29;2(1):33-38. doi: 10.1002/mdc3.12104. eCollection 2015 Mar. Mov Disord Clin Pract. 2014. PMID: 30363831 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous